El-Heneidy A, Grimwood K, Rajmokan M, Shrestha A, Lambert S, Ware R. Nirsevimab provides age-specific protection against RSV hospitalisation in the first year of life: a population-level study in Queensland, Australia. Commun Dis Intell (2018) [Internet]. 2026 Oct. 20 [cited 2026 Oct. 21];50. Available from: https://ojs.cdi.cdc.gov.au/index.php/cdi/article/view/3505